IC Value-Added Distribution Business Market, Global Outlook and Forecast 2023-2029
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 97 |
The global AI-assisted Drug Design (AIDD) market was valued at US$ 1405.9 million in 2022 and is projected to reach US$ 8513.8 million by 2029, at a CAGR of 29.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hardware Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of AI-assisted Drug Design (AIDD) include IBM, Exscientia, Google(Alphabet), Microsoft, Atomwise, Schrodinger, Aitia, Insilico Medicine and NVIDIA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Artificial intelligence (AI) has the potential to revolutionize the drug discovery process,
offering improved efficiency, accuracy, and speed.
This report aims to provide a comprehensive presentation of the global market for AI-assisted Drug Design (AIDD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-assisted Drug Design (AIDD). This report contains market size and forecasts of AI-assisted Drug Design (AIDD) in global, including the following market information:
Global AI-assisted Drug Design (AIDD) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the AI-assisted Drug Design (AIDD) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AI-assisted Drug Design (AIDD) Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global AI-assisted Drug Design (AIDD) Market Segment Percentages, by Type, 2022 (%)
Hardware
Software
Service
Global AI-assisted Drug Design (AIDD) Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global AI-assisted Drug Design (AIDD) Market Segment Percentages, by Application, 2022 (%)
Early Drug Discovery
Preclinical Phase
Clinical Phase
Regulatory Approval
Global AI-assisted Drug Design (AIDD) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global AI-assisted Drug Design (AIDD) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AI-assisted Drug Design (AIDD) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies AI-assisted Drug Design (AIDD) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IBM
Exscientia
Google(Alphabet)
Microsoft
Atomwise
Schrodinger
Aitia
Insilico Medicine
NVIDIA
XtalPi
BPGbio
Owkin
CytoReason
Deep Genomics
Cloud Pharmaceuticals
BenevolentAI
Cyclica
Verge Genomics
Valo Health
Envisagenics
Euretos
BioAge Labs
Iktos
BioSymetrics
Evaxion Biotech
Aria Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of AI-assisted Drug Design (AIDD), market overview.
Chapter 2: Global AI-assisted Drug Design (AIDD) market size in revenue.
Chapter 3: Detailed analysis of AI-assisted Drug Design (AIDD) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of AI-assisted Drug Design (AIDD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 AI-assisted Drug Design (AIDD) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global AI-assisted Drug Design (AIDD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global AI-assisted Drug Design (AIDD) Overall Market Size
2.1 Global AI-assisted Drug Design (AIDD) Market Size: 2022 VS 2029
2.2 Global AI-assisted Drug Design (AIDD) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top AI-assisted Drug Design (AIDD) Players in Global Market
3.2 Top Global AI-assisted Drug Design (AIDD) Companies Ranked by Revenue
3.3 Global AI-assisted Drug Design (AIDD) Revenue by Companies
3.4 Top 3 and Top 5 AI-assisted Drug Design (AIDD) Companies in Global Market, by Revenue in 2022
3.5 Global Companies AI-assisted Drug Design (AIDD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 AI-assisted Drug Design (AIDD) Players in Global Market
3.6.1 List of Global Tier 1 AI-assisted Drug Design (AIDD) Companies
3.6.2 List of Global Tier 2 and Tier 3 AI-assisted Drug Design (AIDD) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global AI-assisted Drug Design (AIDD) Market Size Markets, 2022 & 2029
4.1.2 Hardware
4.1.3 Software
4.1.4 Service
4.2 By Type - Global AI-assisted Drug Design (AIDD) Revenue & Forecasts
4.2.1 By Type - Global AI-assisted Drug Design (AIDD) Revenue, 2018-2023
4.2.2 By Type - Global AI-assisted Drug Design (AIDD) Revenue, 2024-2029
4.2.3 By Type - Global AI-assisted Drug Design (AIDD) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global AI-assisted Drug Design (AIDD) Market Size, 2022 & 2029
5.1.2 Early Drug Discovery
5.1.3 Preclinical Phase
5.1.4 Clinical Phase
5.1.5 Regulatory Approval
5.2 By Application - Global AI-assisted Drug Design (AIDD) Revenue & Forecasts
5.2.1 By Application - Global AI-assisted Drug Design (AIDD) Revenue, 2018-2023
5.2.2 By Application - Global AI-assisted Drug Design (AIDD) Revenue, 2024-2029
5.2.3 By Application - Global AI-assisted Drug Design (AIDD) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global AI-assisted Drug Design (AIDD) Market Size, 2022 & 2029
6.2 By Region - Global AI-assisted Drug Design (AIDD) Revenue & Forecasts
6.2.1 By Region - Global AI-assisted Drug Design (AIDD) Revenue, 2018-2023
6.2.2 By Region - Global AI-assisted Drug Design (AIDD) Revenue, 2024-2029
6.2.3 By Region - Global AI-assisted Drug Design (AIDD) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America AI-assisted Drug Design (AIDD) Revenue, 2018-2029
6.3.2 US AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.3.3 Canada AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.3.4 Mexico AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe AI-assisted Drug Design (AIDD) Revenue, 2018-2029
6.4.2 Germany AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.4.3 France AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.4.4 U.K. AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.4.5 Italy AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.4.6 Russia AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.4.7 Nordic Countries AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.4.8 Benelux AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia AI-assisted Drug Design (AIDD) Revenue, 2018-2029
6.5.2 China AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.5.3 Japan AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.5.4 South Korea AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.5.5 Southeast Asia AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.5.6 India AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America AI-assisted Drug Design (AIDD) Revenue, 2018-2029
6.6.2 Brazil AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.6.3 Argentina AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa AI-assisted Drug Design (AIDD) Revenue, 2018-2029
6.7.2 Turkey AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.7.3 Israel AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.7.4 Saudi Arabia AI-assisted Drug Design (AIDD) Market Size, 2018-2029
6.7.5 UAE AI-assisted Drug Design (AIDD) Market Size, 2018-2029
7 AI-assisted Drug Design (AIDD) Companies Profiles
7.1 IBM
7.1.1 IBM Company Summary
7.1.2 IBM Business Overview
7.1.3 IBM AI-assisted Drug Design (AIDD) Major Product Offerings
7.1.4 IBM AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.1.5 IBM Key News & Latest Developments
7.2 Exscientia
7.2.1 Exscientia Company Summary
7.2.2 Exscientia Business Overview
7.2.3 Exscientia AI-assisted Drug Design (AIDD) Major Product Offerings
7.2.4 Exscientia AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.2.5 Exscientia Key News & Latest Developments
7.3 Google(Alphabet)
7.3.1 Google(Alphabet) Company Summary
7.3.2 Google(Alphabet) Business Overview
7.3.3 Google(Alphabet) AI-assisted Drug Design (AIDD) Major Product Offerings
7.3.4 Google(Alphabet) AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.3.5 Google(Alphabet) Key News & Latest Developments
7.4 Microsoft
7.4.1 Microsoft Company Summary
7.4.2 Microsoft Business Overview
7.4.3 Microsoft AI-assisted Drug Design (AIDD) Major Product Offerings
7.4.4 Microsoft AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.4.5 Microsoft Key News & Latest Developments
7.5 Atomwise
7.5.1 Atomwise Company Summary
7.5.2 Atomwise Business Overview
7.5.3 Atomwise AI-assisted Drug Design (AIDD) Major Product Offerings
7.5.4 Atomwise AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.5.5 Atomwise Key News & Latest Developments
7.6 Schrodinger
7.6.1 Schrodinger Company Summary
7.6.2 Schrodinger Business Overview
7.6.3 Schrodinger AI-assisted Drug Design (AIDD) Major Product Offerings
7.6.4 Schrodinger AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.6.5 Schrodinger Key News & Latest Developments
7.7 Aitia
7.7.1 Aitia Company Summary
7.7.2 Aitia Business Overview
7.7.3 Aitia AI-assisted Drug Design (AIDD) Major Product Offerings
7.7.4 Aitia AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.7.5 Aitia Key News & Latest Developments
7.8 Insilico Medicine
7.8.1 Insilico Medicine Company Summary
7.8.2 Insilico Medicine Business Overview
7.8.3 Insilico Medicine AI-assisted Drug Design (AIDD) Major Product Offerings
7.8.4 Insilico Medicine AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.8.5 Insilico Medicine Key News & Latest Developments
7.9 NVIDIA
7.9.1 NVIDIA Company Summary
7.9.2 NVIDIA Business Overview
7.9.3 NVIDIA AI-assisted Drug Design (AIDD) Major Product Offerings
7.9.4 NVIDIA AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.9.5 NVIDIA Key News & Latest Developments
7.10 XtalPi
7.10.1 XtalPi Company Summary
7.10.2 XtalPi Business Overview
7.10.3 XtalPi AI-assisted Drug Design (AIDD) Major Product Offerings
7.10.4 XtalPi AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.10.5 XtalPi Key News & Latest Developments
7.11 BPGbio
7.11.1 BPGbio Company Summary
7.11.2 BPGbio Business Overview
7.11.3 BPGbio AI-assisted Drug Design (AIDD) Major Product Offerings
7.11.4 BPGbio AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.11.5 BPGbio Key News & Latest Developments
7.12 Owkin
7.12.1 Owkin Company Summary
7.12.2 Owkin Business Overview
7.12.3 Owkin AI-assisted Drug Design (AIDD) Major Product Offerings
7.12.4 Owkin AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.12.5 Owkin Key News & Latest Developments
7.13 CytoReason
7.13.1 CytoReason Company Summary
7.13.2 CytoReason Business Overview
7.13.3 CytoReason AI-assisted Drug Design (AIDD) Major Product Offerings
7.13.4 CytoReason AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.13.5 CytoReason Key News & Latest Developments
7.14 Deep Genomics
7.14.1 Deep Genomics Company Summary
7.14.2 Deep Genomics Business Overview
7.14.3 Deep Genomics AI-assisted Drug Design (AIDD) Major Product Offerings
7.14.4 Deep Genomics AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.14.5 Deep Genomics Key News & Latest Developments
7.15 Cloud Pharmaceuticals
7.15.1 Cloud Pharmaceuticals Company Summary
7.15.2 Cloud Pharmaceuticals Business Overview
7.15.3 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Major Product Offerings
7.15.4 Cloud Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.15.5 Cloud Pharmaceuticals Key News & Latest Developments
7.16 BenevolentAI
7.16.1 BenevolentAI Company Summary
7.16.2 BenevolentAI Business Overview
7.16.3 BenevolentAI AI-assisted Drug Design (AIDD) Major Product Offerings
7.16.4 BenevolentAI AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.16.5 BenevolentAI Key News & Latest Developments
7.17 Cyclica
7.17.1 Cyclica Company Summary
7.17.2 Cyclica Business Overview
7.17.3 Cyclica AI-assisted Drug Design (AIDD) Major Product Offerings
7.17.4 Cyclica AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.17.5 Cyclica Key News & Latest Developments
7.18 Verge Genomics
7.18.1 Verge Genomics Company Summary
7.18.2 Verge Genomics Business Overview
7.18.3 Verge Genomics AI-assisted Drug Design (AIDD) Major Product Offerings
7.18.4 Verge Genomics AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.18.5 Verge Genomics Key News & Latest Developments
7.19 Valo Health
7.19.1 Valo Health Company Summary
7.19.2 Valo Health Business Overview
7.19.3 Valo Health AI-assisted Drug Design (AIDD) Major Product Offerings
7.19.4 Valo Health AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.19.5 Valo Health Key News & Latest Developments
7.20 Envisagenics
7.20.1 Envisagenics Company Summary
7.20.2 Envisagenics Business Overview
7.20.3 Envisagenics AI-assisted Drug Design (AIDD) Major Product Offerings
7.20.4 Envisagenics AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.20.5 Envisagenics Key News & Latest Developments
7.21 Euretos
7.21.1 Euretos Company Summary
7.21.2 Euretos Business Overview
7.21.3 Euretos AI-assisted Drug Design (AIDD) Major Product Offerings
7.21.4 Euretos AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.21.5 Euretos Key News & Latest Developments
7.22 BioAge Labs
7.22.1 BioAge Labs Company Summary
7.22.2 BioAge Labs Business Overview
7.22.3 BioAge Labs AI-assisted Drug Design (AIDD) Major Product Offerings
7.22.4 BioAge Labs AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.22.5 BioAge Labs Key News & Latest Developments
7.23 Iktos
7.23.1 Iktos Company Summary
7.23.2 Iktos Business Overview
7.23.3 Iktos AI-assisted Drug Design (AIDD) Major Product Offerings
7.23.4 Iktos AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.23.5 Iktos Key News & Latest Developments
7.24 BioSymetrics
7.24.1 BioSymetrics Company Summary
7.24.2 BioSymetrics Business Overview
7.24.3 BioSymetrics AI-assisted Drug Design (AIDD) Major Product Offerings
7.24.4 BioSymetrics AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.24.5 BioSymetrics Key News & Latest Developments
7.25 Evaxion Biotech
7.25.1 Evaxion Biotech Company Summary
7.25.2 Evaxion Biotech Business Overview
7.25.3 Evaxion Biotech AI-assisted Drug Design (AIDD) Major Product Offerings
7.25.4 Evaxion Biotech AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.25.5 Evaxion Biotech Key News & Latest Developments
7.26 Aria Pharmaceuticals
7.26.1 Aria Pharmaceuticals Company Summary
7.26.2 Aria Pharmaceuticals Business Overview
7.26.3 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Major Product Offerings
7.26.4 Aria Pharmaceuticals AI-assisted Drug Design (AIDD) Revenue in Global Market (2018-2023)
7.26.5 Aria Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 97 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 144 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 131 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 113 |
Price : US $3250 | Date : May 2023 |
CAT ID : 8 | Pages : 92 |
24/7 Research support
Quality assurance
Information security